3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Conditions
Squamous Cell Carcinoma of Head and Neck
3
Sarcoma
3
Carcinoma, Non-Small-Cell Lung
3
Brain Neoplasms
3
Rhabdomyosarcoma
2
Prostatic Neoplasms
2
Osteosarcoma
2
Esophageal Neoplasms
2
Craniopharyngioma
2
Wilms Tumor
1
Vascular Neoplasms
1
Solitary Fibrous Tumors
1
Solid Tumor
1
Smooth Muscle Tumor
1
Sarcoma, Ewing
1
Sarcoma, Clear Cell
1
Recurrent Head and Neck Carcinoma
1
Oligodendroglioma
1
Neurofibrosarcoma
1
Neuroblastoma
1
Nerve Sheath Neoplasms
1
Neoplasms, Adipose Tissue
1
Neoplasms
1
Nasopharyngeal Carcinoma
1
Myoepithelioma
1
Mesothelioma, Malignant
1
Meningioma
1
Liposarcoma, Myxoid
1
Liposarcoma
1
Hodgkin Disease
1
Interventions
Cisplatin
6
Platinum
5
Pemetrexed
5
1,2-diaminocyclohexaneplatinum II citrate
5
pembrolizumab
4
atezolizumab
2
Radiotherapy
2
Radiation
2
Nivolumab
2
Ipilimumab
2
Gemcitabine
2
Cyclophosphamide
2
Carboplatin
2
tremelimumab
1
methoxyamine
1
fludarabine
1
decitabine and cedazuridine drug combination
1
cediranib
1
anetumab ravtansine
1
aldesleukin
1
Trioxsalen
1
Tissue Banks
1
Radiotherapy, Intensity-Modulated
1
Proton Therapy
1
Phototherapy
1
Photochemotherapy
1
Pharmacogenomic Testing
1
Pharmaceutical Preparations
1
Interleukin-2
1
Influenza Vaccines
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Mesothelioma, Malignant
×
Proton Therapy
×
90 days
×
Clear all
NCT05655078
2026-03-30
HIT-Meso
University College, London
Phase NA
Recruiting
148 enrolled